These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25966666)

  • 21. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway.
    Tan B; Shen L; Yang K; Huang D; Li X; Li Y; Zhao L; Chen J; Yi Q; Xu H; Tian J; Zhu J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):78-85. PubMed ID: 29050939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells.
    Shinojima N; Hossain A; Takezaki T; Fueyo J; Gumin J; Gao F; Nwajei F; Marini FC; Andreeff M; Kuratsu J; Lang FF
    Cancer Res; 2013 Apr; 73(7):2333-44. PubMed ID: 23365134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells.
    Di GH; Liu Y; Lu Y; Liu J; Wu C; Duan HF
    PLoS One; 2014; 9(11):e113572. PubMed ID: 25419563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal communication in glioma - a review.
    Xu H; Zhang K; Zong H; Shang M; Li K; He X
    J BUON; 2016; 21(6):1368-1373. PubMed ID: 28039693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells and glioma cells form a structural as well as a functional syncytium in vitro.
    Schichor C; Albrecht V; Korte B; Buchner A; Riesenberg R; Mysliwietz J; Paron I; Motaln H; Turnšek TL; Jürchott K; Selbig J; Tonn JC
    Exp Neurol; 2012 Mar; 234(1):208-19. PubMed ID: 22230665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways.
    Vigo T; Procaccini C; Ferrara G; Baranzini S; Oksenberg JR; Matarese G; Diaspro A; Kerlero de Rosbo N; Uccelli A
    J Allergy Clin Immunol; 2017 May; 139(5):1667-1676. PubMed ID: 27670240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
    Mi F; Gong L
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
    Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
    Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1.
    Sun T; Lin B; Sun Q; Zhang X; Wang T; Yang J; Liu X; Lu H; Lu N; Zhao K
    Phytomedicine; 2024 Sep; 135():156070. PubMed ID: 39326139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation and malignant transformation of MSCs with the overexpression of SIL-R/GP130 under the tumor microenvironment.
    Hou Z; Cui N; Cui Y; Xing H; Liu W
    Med Oncol; 2015 Jan; 32(1):328. PubMed ID: 25433944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML.
    Aldaz P; Martín-Martín N; Saenz-Antoñanzas A; Carrasco-Garcia E; Álvarez-Satta M; Elúa-Pinin A; Pollard SM; Lawrie CH; Moreno-Valladares M; Samprón N; Hench J; Lovell-Badge R; Carracedo A; Matheu A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells.
    Park CG; Choi SH; Lee SY; Eun K; Park MG; Jang J; Jeong HJ; Kim SJ; Jeong S; Lee K; Kim H
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.
    Egea V; von Baumgarten L; Schichor C; Berninger B; Popp T; Neth P; Goldbrunner R; Kienast Y; Winkler F; Jochum M; Ries C
    Cell Death Differ; 2011 May; 18(5):853-63. PubMed ID: 21127499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.